Sorrento Therapeutics Inc (SRNE): I like Chuck's list, and especially...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	57
Posts	5700
Boards Moderated	0
Alias Born	12/13/2004

dia76ca

Re: None

Monday, 01/17/2022 5:52:58 PM

Monday, January 17, 2022 5:52:58 PM

I like Chuck's list, and especially that we could get all these items, beginning this week and over the next 6 weeks.
"1) results of AMG and DROPS trials with > 90% reduced hospitalization along with announced full efficacy against omicron
2) results of MSC trial with greater than 95% survival of late stage ARDS
3) full readouts on SP-102 and submission for NDA
4) approval in China of Abivertinib for NSCLC
5) approvals for Lee Pharma biobetter
6) global partnerships for Abivertinib
7) manufacturing registration of SRNE for STIX and EUA by FDA
8) partnership with amgen on Sofusa LDS
9) IND on MPI8 and phased multiple trials for P1, P2, P3 progression
10) many others…so many items are on deck for near terms pivotal results…"

"The refusal of the real is the number one dogma of our time" Rene Girard

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent SRNE News

Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 09:31:06 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/27/2023 08:15:31 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2023 01:51:06 AM
Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2023 09:25:07 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/07/2023 08:15:35 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2023 10:01:54 AM
Form 8-K - Current report • Edgar (US Regulatory) • 07/13/2023 10:26:26 AM